These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteria. Kothavade RJ; Dhurat RS; Mishra SN; Kothavade UR Eur J Clin Microbiol Infect Dis; 2013 Feb; 32(2):161-88. PubMed ID: 23139042 [TBL] [Abstract][Full Text] [Related]
10. Restoring Pulmonary and Sleep Services as the COVID-19 Pandemic Lessens. From an Association of Pulmonary, Critical Care, and Sleep Division Directors and American Thoracic Society-coordinated Task Force. Wilson KC; Kaminsky DA; Michaud G; Sharma S; Nici L; Folz RJ; Barjaktarevic I; Bhakta NR; Cheng G; Chupp GL; Cole A; Dixon AE; Finigan JH; Graham B; Hallstrand TS; Haynes J; Hankinson J; MacIntyre N; Mandel J; McCarthy K; McCormack M; Patil SP; Rosenfeld M; Senitko M; Sethi S; Swenson ER; Stanojevic S; Teodorescu M; Weiner DJ; Wiener RS; Powell CA Ann Am Thorac Soc; 2020 Nov; 17(11):1343-1351. PubMed ID: 32663071 [No Abstract] [Full Text] [Related]
11. Nontuberculous Mycobacterial Pulmonary Disease: A Clinical and Radiologic Update. Nguyen I; Green O; Modahl L Semin Roentgenol; 2022 Jan; 57(1):75-89. PubMed ID: 35090712 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2012 Dec; 12():CD010004. PubMed ID: 23235684 [TBL] [Abstract][Full Text] [Related]
13. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2014 Dec; (12):CD010004. PubMed ID: 25470304 [TBL] [Abstract][Full Text] [Related]
14. An overview of pulmonary infections due to rapidly growing mycobacteria in South Asia and impressions from a subtropical region. Shrivastava K; Kumar C; Singh A; Narang A; Giri A; Sharma NK; Gupta S; Chauhan V; Gunasekaran J; Balasubramanian V; Chaudhry A; Singla R; Prasad R; Varma-Basil M Int J Mycobacteriol; 2020; 9(1):62-70. PubMed ID: 32474491 [TBL] [Abstract][Full Text] [Related]
15. Cough Due to TB and Other Chronic Infections: CHEST Guideline and Expert Panel Report. Field SK; Escalante P; Fisher DA; Ireland B; Irwin RS; Chest; 2018 Feb; 153(2):467-497. PubMed ID: 29196066 [TBL] [Abstract][Full Text] [Related]
16. Clinical Practice Guideline: Evaluation of the Neck Mass in Adults. Pynnonen MA; Gillespie MB; Roman B; Rosenfeld RM; Tunkel DE; Bontempo L; Brook I; Chick DA; Colandrea M; Finestone SA; Fowler JC; Griffith CC; Henson Z; Levine C; Mehta V; Salama A; Scharpf J; Shatzkes DR; Stern WB; Youngerman JS; Corrigan MD Otolaryngol Head Neck Surg; 2017 Sep; 157(2_suppl):S1-S30. PubMed ID: 28891406 [TBL] [Abstract][Full Text] [Related]
17. [Clinical importance of Mycobacterium kansasii and evaluation of the need to identify nontuberculous mycobacteria]. Etxebarrieta M; Rodrigo A; Martín C; Ojer M; Ruz A; Dorronsoro I Enferm Infecc Microbiol Clin; 2002 Mar; 20(3):113-6. PubMed ID: 11904083 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology and risk factors associated with NTM pulmonary and extrapulmonary infections in a high tuberculosis endemic Region. Wani SR; Wattal C; Raveendran R Indian J Med Microbiol; 2020; 38(2):169-175. PubMed ID: 32883930 [TBL] [Abstract][Full Text] [Related]
19. Clinical relevance and diagnosis of nontuberculous mycobacterial pulmonary disease in populations at risk. Feng JY; Chen WC; Chen YY; Su WJ J Formos Med Assoc; 2020 Jun; 119 Suppl 1():S23-S31. PubMed ID: 32482607 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Brown-Elliott BA; Nash KA; Wallace RJ Clin Microbiol Rev; 2012 Jul; 25(3):545-82. PubMed ID: 22763637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]